FR2476084A1 - Composes de tetrahydrofuranyl-sulfonium et de tetrahydropyranyl-sulfonium, leur preparation et medicaments contenant ces substances - Google Patents

Composes de tetrahydrofuranyl-sulfonium et de tetrahydropyranyl-sulfonium, leur preparation et medicaments contenant ces substances Download PDF

Info

Publication number
FR2476084A1
FR2476084A1 FR8102956A FR8102956A FR2476084A1 FR 2476084 A1 FR2476084 A1 FR 2476084A1 FR 8102956 A FR8102956 A FR 8102956A FR 8102956 A FR8102956 A FR 8102956A FR 2476084 A1 FR2476084 A1 FR 2476084A1
Authority
FR
France
Prior art keywords
tetrahydro
compound
sulfonium
furanyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8102956A
Other languages
English (en)
French (fr)
Other versions
FR2476084B1 (https=
Inventor
Akihide Koda
Mikio Hori
Mitsugi Yasumoto
Ichiro Yamawaki
Yuji Yamada
Katsuo Takikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1838580A external-priority patent/JPS56123977A/ja
Priority claimed from JP850081A external-priority patent/JPS57122074A/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of FR2476084A1 publication Critical patent/FR2476084A1/fr
Application granted granted Critical
Publication of FR2476084B1 publication Critical patent/FR2476084B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8102956A 1980-02-15 1981-02-16 Composes de tetrahydrofuranyl-sulfonium et de tetrahydropyranyl-sulfonium, leur preparation et medicaments contenant ces substances Granted FR2476084A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1838580A JPS56123977A (en) 1980-02-15 1980-02-15 Sulfonium compound and its preparation
JP850081A JPS57122074A (en) 1981-01-21 1981-01-21 Sulfonium compound and its preparation

Publications (2)

Publication Number Publication Date
FR2476084A1 true FR2476084A1 (fr) 1981-08-21
FR2476084B1 FR2476084B1 (https=) 1983-07-08

Family

ID=26343021

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8102956A Granted FR2476084A1 (fr) 1980-02-15 1981-02-16 Composes de tetrahydrofuranyl-sulfonium et de tetrahydropyranyl-sulfonium, leur preparation et medicaments contenant ces substances

Country Status (10)

Country Link
US (1) US4581372A (https=)
AU (1) AU522849B2 (https=)
CA (1) CA1169080A (https=)
CH (1) CH647771A5 (https=)
DE (1) DE3105303C2 (https=)
ES (1) ES500077A0 (https=)
FR (1) FR2476084A1 (https=)
GB (1) GB2070597B (https=)
IT (1) IT1172224B (https=)
NL (1) NL8100753A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2332709A1 (de) * 1972-06-30 1974-01-10 Ciba Geigy Ag Verfahren zur herstellung von sulfoniumsalzen
FR2301234A1 (fr) * 1975-02-19 1976-09-17 Whitefin Holding Sa Derive de dimercaptoethyl ether

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2562042A (en) * 1949-09-19 1951-07-24 American Home Foods Inc Tetrahydropyran-sulfide compounds
US3455956A (en) * 1965-02-24 1969-07-15 Takeda Chemical Industries Ltd Dialkyl-sulfoxides and dialkyl-sulfones

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2332709A1 (de) * 1972-06-30 1974-01-10 Ciba Geigy Ag Verfahren zur herstellung von sulfoniumsalzen
FR2301234A1 (fr) * 1975-02-19 1976-09-17 Whitefin Holding Sa Derive de dimercaptoethyl ether

Also Published As

Publication number Publication date
GB2070597A (en) 1981-09-09
US4581372A (en) 1986-04-08
AU6723481A (en) 1981-08-20
ES8201568A1 (es) 1982-01-01
DE3105303A1 (de) 1981-12-17
CA1169080A (en) 1984-06-12
NL8100753A (nl) 1981-09-16
GB2070597B (en) 1983-07-27
ES500077A0 (es) 1982-01-01
IT8167206A0 (it) 1981-02-13
CH647771A5 (de) 1985-02-15
DE3105303C2 (de) 1985-01-03
IT1172224B (it) 1987-06-18
AU522849B2 (en) 1982-07-01
FR2476084B1 (https=) 1983-07-08

Similar Documents

Publication Publication Date Title
DE69520880T2 (de) 9-deoxotaxan verbindungen
DE3884517T2 (de) Biologisch aktive Carbonsäureester.
DE69429173T2 (de) Taxolderivate
KR20210087435A (ko) 일루딘 유사체, 이의 용도, 및 이의 합성 방법
US4788216A (en) Medicinal uses for podophyllotoxins
EP0157267B1 (de) Substituierte Benzopyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0189370A2 (de) Spiro-dioxolane, -dithiolane und -oxothiolane
EP0209770A1 (fr) Esters et amides de l'acide eicosatriynoique et leur application en pharmacie et en cosmétique
DE69610085T2 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69218196T2 (de) Cholesterinsenkende tocopherolanaloga
FR2476084A1 (fr) Composes de tetrahydrofuranyl-sulfonium et de tetrahydropyranyl-sulfonium, leur preparation et medicaments contenant ces substances
CH643254A5 (fr) Analogues de la prostaglandine i(1) et compositions pharmaceutiques les contenant.
JPH01199960A (ja) 同化作用を有するゼアララノール誘導体
BE1000625A3 (fr) Sels d'acide (3s(z)) -2 (((1-(2-amino-4-thiazolyl)-2- ((2,2-dimethyl-4-oxo-1- (sulfooxy) -3-azetidinyl) amino) -2-oxoethylidene) amino) oxo) acetique, leur preparation et leur utilisation.
DK158946B (da) Analogifremgangsmaade til fremstilling af furylsubstituerede polyener
MC1549A1 (fr) Anthracycline-glycosides,procede pour leur preparation et medicaments les contenant
US4614747A (en) Derivatives of alpha-alkyl polyolefinic carboxylic acid useful in the treatment of psoriasis
US4704462A (en) Substituted 2,3,3a,6-tetrahydro-6-oxobenzofuran derivative useful as PAF antagonist
EP0659728A1 (en) 4-hydroxy-2-cyclopentenone derivative and carcinostatic and osteogenesis promoter containing the same
KR100516647B1 (ko) 당뇨병 치료제 조성물
KR0128513B1 (ko) 신규한 항균성 페넴 유도체와 그의 제조방법
US4647412A (en) Anti-tumor derivatives of butanediol and process of preparation
JPH11349478A (ja) 抗癌剤
DD140047A5 (de) Verfahren zur herstellung racemischer und optisch aktiver halbprostanoid-glycoside und-thioglycoside
US5250673A (en) 2'-deoxy-5-substituted uridine derivatives

Legal Events

Date Code Title Description
ST Notification of lapse